Responses

Download PDFPDF

Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Mortality or incidence?

    Dear Editor,

    In their paper entitled “Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public”, Svec et. al.[1] clearly imply that they believe mortality is an acceptable surrogate for incidence of haematological malignancy in this study group. Although they offer certain caveats regarding this approach, they ignore the greatest potential confounder. Patients with...

    Show More
    Conflict of Interest:
    None declared.